Nutrien

Farmers continue to treat crop nutrients as yield-protecting necessities, so baseline demand remains resilient even after the 2022 fertilizer price spike unwinds. If this holds, Nutrien has a demand floor through the cycle; if it breaks, revenue and utilization become far more commodity-like.

Nutrien’s margin recovery depends on global potash, nitrogen, and phosphate supply staying disciplined enough that its scale can convert price normalization into gross profit rather than volume-only growth. This determines whether Nutrien earns attractive mid-cycle returns or merely passes through volatile commodity prices.

The business has operating leverage to a healthier fertilizer cycle, but that leverage must come from sustainable utilization and pricing rather than a one-off rebound from the weak 2024 base. If operating leverage is durable, equity value can compound from normalized earnings; if it is only cyclical snapback, owners should not capitalize it at a high multiple.

Nutrien must keep converting cyclical earnings into operating cash flow through working-capital swings, because fertilizer scale only creates owner value if cash is not trapped in inventory and receivables. Cash conversion funds dividends, buybacks, debt reduction, and reinvestment; weak conversion would turn accounting earnings into a lower-quality cycle bet.

Management must preserve balance-sheet flexibility through the commodity cycle rather than using peak-cycle confidence to add leverage or overbuild capacity. A strong balance sheet lets Nutrien invest and return capital when the cycle is weak; leverage at the wrong point would make the equity much more exposed to fertilizer downturns.